Correlation Between CellaVision and Dedicare
Can any of the company-specific risk be diversified away by investing in both CellaVision and Dedicare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CellaVision and Dedicare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CellaVision AB and Dedicare AB, you can compare the effects of market volatilities on CellaVision and Dedicare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CellaVision with a short position of Dedicare. Check out your portfolio center. Please also check ongoing floating volatility patterns of CellaVision and Dedicare.
Diversification Opportunities for CellaVision and Dedicare
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CellaVision and Dedicare is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding CellaVision AB and Dedicare AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dedicare AB and CellaVision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CellaVision AB are associated (or correlated) with Dedicare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dedicare AB has no effect on the direction of CellaVision i.e., CellaVision and Dedicare go up and down completely randomly.
Pair Corralation between CellaVision and Dedicare
Assuming the 90 days trading horizon CellaVision AB is expected to under-perform the Dedicare. In addition to that, CellaVision is 1.23 times more volatile than Dedicare AB. It trades about -0.12 of its total potential returns per unit of risk. Dedicare AB is currently generating about -0.12 per unit of volatility. If you would invest 7,010 in Dedicare AB on August 31, 2024 and sell it today you would lose (1,040) from holding Dedicare AB or give up 14.84% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 98.46% |
Values | Daily Returns |
CellaVision AB vs. Dedicare AB
Performance |
Timeline |
CellaVision AB |
Dedicare AB |
CellaVision and Dedicare Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CellaVision and Dedicare
The main advantage of trading using opposite CellaVision and Dedicare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CellaVision position performs unexpectedly, Dedicare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dedicare will offset losses from the drop in Dedicare's long position.CellaVision vs. Cantargia AB | CellaVision vs. BioArctic AB | CellaVision vs. Oncopeptides AB | CellaVision vs. Hansa Biopharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |